Minimal Residual Disease, Deep Sequencing, And Prognosis In Multiple Myeloma The Myeloma Beacon For patients 65 and older, the first line of therapy included only induction therapy without a stem cell transplant. Only patients who achieved at least a very good partial response following their first line of therapy were included. The mean patient ... |
